Arrayit (OTCPK:ARYC) - Stock Price, News & Analysis

ARYC Stock Overview

A life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. More details

ARYC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($1K)

Latest financial reports are more than a year old

Shares are highly illiquid

Arrayit Corporation Competitors

eFFECTOR Therapeutics

OTCPK:EFTR

US$940.0

Item 9 Labs

OTCPK:INLB

US$701.0

BZAM

OTCPK:BZAM.F

US$270.0

Genocea Biosciences

OTCPK:GNCA.Q

US$5.9k

Price History & Performance

Summary of all time highs, changes and price drops for Arrayit
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	0%
5 Year Change	-100.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ARYC	US Life Sciences	US Market
7D	0%	1.9%	0.5%
1Y	n/a	3.3%	30.7%

Return vs Industry: Insufficient data to determine how ARYC performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how ARYC performed against the US Market.

Price Volatility

Is ARYC's price volatile compared to industry and market?
ARYC volatility
ARYC Average Weekly Movement	n/a
Life Sciences Industry Average Movement	8.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: ARYC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine ARYC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Rene Schena	www.arrayit.com

Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. The company is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. It offers microarray printing technology, which allows the manufacture of DNA, protein, antibody, lipid, carbohydrate, and other types of microarrays for research and diagnostic applications, including gene expression, genotyping, protein profiling, and others.

Arrayit Corporation Fundamentals Summary

How do Arrayit's earnings and revenue compare to its market cap?
ARYC fundamental statistics
Market cap	US$1.13k
Earnings (TTM)	-US$6.53m
Revenue (TTM)	US$2.82m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is ARYC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ARYC income statement (TTM)
Revenue	US$2.82m
Cost of Revenue	US$1.43m
Gross Profit	US$1.39m
Other Expenses	US$7.92m
Earnings	-US$6.53m

Last Reported Earnings

Sep 30, 2015

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did ARYC perform over the long term?

See historical performance and comparison